| scholarly article | Q13442814 |
| P50 | author | John M. Luk | Q42935545 |
| P2093 | author name string | Hong Shen | |
| Zheng Zhou | |||
| Ning Qin | |||
| Zhiheng Xu | |||
| Taishan Hu | |||
| Yiping Rong | |||
| Teng Feng | |||
| Xiongwen Zhang | |||
| Zhisen Zhang | |||
| Zhaohu Lin | |||
| Liangcheng Zhu | |||
| P2860 | cites work | Phasercrystallographic software | Q27860930 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 724-732 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides | |
| P478 | volume | 29 |
| Q26782842 | A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas |
| Q30276357 | An evolutionary, structural and functional overview of the mammalian TEAD1 and TEAD2 transcription factors. |
| Q59330203 | Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity |
| Q36703469 | Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway |
| Q38514410 | Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway |
| Q33700457 | Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex |
| Q35269102 | Disease implications of the Hippo/YAP pathway |
| Q37718419 | Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma |
| Q47133162 | Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets. |
| Q42201432 | Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit. |
| Q26771285 | Mechanisms of Hippo pathway regulation |
| Q58787445 | Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms |
| Q39654967 | MicroRNA-186 targets Yes-associated protein 1 to inhibit Hippo signaling and tumorigenesis in hepatocellular carcinoma |
| Q89413473 | Microenvironment and tumor cells: two targets for new molecular therapies of hepatocellular carcinoma |
| Q88637038 | Multifaceted regulation and functions of YAP/TAZ in tumors (Review) |
| Q38371893 | Overexpression of Yes-associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta-analysis |
| Q48009516 | Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas |
| Q36142754 | Probing for a deeper understanding of rhabdomyosarcoma: insights from complementary model systems. |
| Q90727399 | Pulmonary Arterial Stiffness: An Early and Pervasive Driver of Pulmonary Arterial Hypertension |
| Q88229231 | Regulation of the Hippo pathway in cancer biology |
| Q28066930 | Repair Injured Heart by Regulating Cardiac Regenerative Signals |
| Q33751702 | Targeting YAP/TAZ-TEAD protein-protein interactions using fragment-based and computational modeling approaches. |
| Q52642770 | Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma. |
| Q54120370 | Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors. |
| Q58609599 | Targeting the Hippo Pathway for Breast Cancer Therapy |
| Q90482955 | The HIPPO pathway in gynecological malignancies |
| Q90278837 | The Hippo Pathway in Prostate Cancer |
| Q64923650 | The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin. |
| Q55261227 | Toward the Discovery of a Novel Class of YAP⁻TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP⁻TEAD Protein⁻Protein Interface. |
| Q92167066 | YAP promotes the proliferation of neuroblastoma cells through decreasing the nuclear location of p27Kip1 mediated by Akt |
| Q33913845 | YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma |
Search more.